Our expertise in medical research is targeted towards creating new vaccines in the areas of unmet need, as well as adapting existing vaccines for more effective delivery, in the low- and middle-income nations. Numerous barriers hamper access to life-saving vaccines for millions of people living in the developing world. Firstly, the lack of commercial return has limited private sector investment in new solutions for diseases that predominantly affect these counties. Secondly, many licensed vaccines available in the market today were developed and manufactured with industrialised world citizens in mind.
Read MoreDeveloping vaccines for global health
Hilleman’s mission is to develop innovative and affordable vaccines and biologics against infectious diseases in low- and middle-income settings until Phase I/II clinical proof of concept and then partner with local and global manufacturers for the large-scale development and distribution.
